Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. While you may have an investing style you rely on, finding great stocks is made ...
A digital representation of a super-sized snowflake ice maze, which is being constructed for the 26th Harbin Ice and Snow World in Harbin, Heilongjiang province. [Photo provided to chinadaily.com ...